DE69427587T2 - Cyclohexandiharnstoff-derivate und verfahren zu deren herstellung - Google Patents
Cyclohexandiharnstoff-derivate und verfahren zu deren herstellungInfo
- Publication number
- DE69427587T2 DE69427587T2 DE69427587T DE69427587T DE69427587T2 DE 69427587 T2 DE69427587 T2 DE 69427587T2 DE 69427587 T DE69427587 T DE 69427587T DE 69427587 T DE69427587 T DE 69427587T DE 69427587 T2 DE69427587 T2 DE 69427587T2
- Authority
- DE
- Germany
- Prior art keywords
- group
- production
- diane
- cyclohexane
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/16—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
- C07C211/18—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings containing at least two amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Furan Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22624793A JP3286745B2 (ja) | 1993-09-10 | 1993-09-10 | シクロヘキサンジウレア誘導体及びその製法 |
PCT/JP1994/001475 WO1995007258A1 (fr) | 1993-09-10 | 1994-09-07 | Derive de cyclohexanediuree et son procede de production |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69427587D1 DE69427587D1 (de) | 2001-08-02 |
DE69427587T2 true DE69427587T2 (de) | 2002-04-25 |
Family
ID=16842204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69427587T Expired - Fee Related DE69427587T2 (de) | 1993-09-10 | 1994-09-07 | Cyclohexandiharnstoff-derivate und verfahren zu deren herstellung |
Country Status (9)
Country | Link |
---|---|
US (1) | US5733931A (de) |
EP (1) | EP0718281B1 (de) |
JP (1) | JP3286745B2 (de) |
KR (1) | KR100320162B1 (de) |
AT (1) | ATE202555T1 (de) |
AU (1) | AU680941B2 (de) |
CA (1) | CA2171295A1 (de) |
DE (1) | DE69427587T2 (de) |
WO (1) | WO1995007258A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW539661B (en) * | 2000-09-12 | 2003-07-01 | Mitsubishi Gas Chemical Co | Amino compound and process for producing the same |
DE10133686C2 (de) * | 2001-07-11 | 2003-07-17 | Osram Opto Semiconductors Gmbh | Organisches, elektrolumineszierendes Display und dessen Herstellung |
US20050119314A1 (en) * | 2002-04-05 | 2005-06-02 | Sankyo Company, Limited | Pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent |
CA2753318A1 (en) * | 2003-05-30 | 2004-12-09 | Ranbaxy Laboratories Limited | Substituted pyrrole derivatives |
US7829552B2 (en) | 2003-11-19 | 2010-11-09 | Metabasis Therapeutics, Inc. | Phosphorus-containing thyromimetics |
KR101021828B1 (ko) * | 2004-10-27 | 2011-03-17 | 다이이찌 산쿄 가부시키가이샤 | 2 이상의 치환기를 갖는 벤젠 화합물 |
US8026377B2 (en) * | 2005-11-08 | 2011-09-27 | Ranbaxy Laboratories, Limited | Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt |
WO2008020314A2 (en) * | 2006-03-14 | 2008-02-21 | Ranbaxy Laboratories Limited | Statin stabilizing dosage formulations |
TW200811101A (en) * | 2006-07-14 | 2008-03-01 | Ranbaxy Lab Ltd | Polymorphic forms of an HMG-CoA reductase inhibitor and uses thereof |
WO2010093601A1 (en) | 2009-02-10 | 2010-08-19 | Metabasis Therapeutics, Inc. | Novel sulfonic acid-containing thyromimetics, and methods for their use |
JP6806562B2 (ja) * | 2013-03-15 | 2021-01-06 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | eIF2α経路の調節因子 |
CN110272588B (zh) * | 2019-06-21 | 2022-07-05 | 广州华新科智造技术有限公司 | 聚丙烯成核剂及其制备方法和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3631107A (en) | 1969-10-24 | 1971-12-28 | Ayerst Mckenna & Harrison | N n'-bis(acenaphthenylmethyl)-cyclohexanebis(methylamines) and the salts thereof |
US3940441A (en) | 1973-02-09 | 1976-02-24 | Sterling Drug Inc. | N,N'-bisphenoxybenzyl-bridged-diamides |
US4119668A (en) | 1975-06-02 | 1978-10-10 | Sterling Drug Inc. | N,N'-Bridged-bis[N,N'substituted-2-hydroxy alkaneammonium] salts |
US5227492A (en) * | 1988-01-20 | 1993-07-13 | Yamanouchi Pharmaceutical Co., Ltd. | Diurea derivatives useful as medicaments and processes for the preparation thereof |
US5166429A (en) * | 1988-01-20 | 1992-11-24 | Yamanouchi Pharmaceutical Co., Ltd. | Diurea derivatives useful as medicaments and processes for the preparation thereof |
JPH02117651A (ja) * | 1988-01-20 | 1990-05-02 | Yamanouchi Pharmaceut Co Ltd | ジウレア誘導体及びその製造法 |
CN1021819C (zh) * | 1988-01-20 | 1993-08-18 | 山之内制药株式会社 | 作为药物有用的双脲衍生物的制备方法 |
-
1993
- 1993-09-10 JP JP22624793A patent/JP3286745B2/ja not_active Expired - Fee Related
-
1994
- 1994-09-07 DE DE69427587T patent/DE69427587T2/de not_active Expired - Fee Related
- 1994-09-07 AU AU76235/94A patent/AU680941B2/en not_active Ceased
- 1994-09-07 EP EP94926366A patent/EP0718281B1/de not_active Expired - Lifetime
- 1994-09-07 CA CA002171295A patent/CA2171295A1/en not_active Abandoned
- 1994-09-07 KR KR1019960701207A patent/KR100320162B1/ko not_active IP Right Cessation
- 1994-09-07 US US08/617,828 patent/US5733931A/en not_active Expired - Fee Related
- 1994-09-07 AT AT94926366T patent/ATE202555T1/de not_active IP Right Cessation
- 1994-09-07 WO PCT/JP1994/001475 patent/WO1995007258A1/ja active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
US5733931A (en) | 1998-03-31 |
EP0718281B1 (de) | 2001-06-27 |
AU680941B2 (en) | 1997-08-14 |
DE69427587D1 (de) | 2001-08-02 |
JP3286745B2 (ja) | 2002-05-27 |
WO1995007258A1 (fr) | 1995-03-16 |
KR100320162B1 (ko) | 2002-11-13 |
KR960704840A (ko) | 1996-10-09 |
AU7623594A (en) | 1995-03-27 |
EP0718281A1 (de) | 1996-06-26 |
JPH0782232A (ja) | 1995-03-28 |
CA2171295A1 (en) | 1995-03-16 |
EP0718281A4 (de) | 1997-11-26 |
ATE202555T1 (de) | 2001-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE255579T1 (de) | Pyrrolidin-derivate die eine phospholipase-a2- hemmende wirkung haben | |
DE69427587T2 (de) | Cyclohexandiharnstoff-derivate und verfahren zu deren herstellung | |
PT705833E (pt) | Derivado de dc-89 | |
BR8704582A (pt) | Processo para preparar derivados de piridinacarboxamida | |
NO965334D0 (no) | Nye 4,6-diarylpyrimidin-derivater og salter derav | |
ATE228132T1 (de) | Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung | |
DE69406323D1 (de) | Substituierte Aminsäure Derivate verwendbar für die Behandlung von Arteriosclerosis | |
NZ248099A (en) | Use of spiro-oxathiolane quinuclidine derivatives for treating sjoegren syndrome | |
ATE196135T1 (de) | Pyridoncarbonsäurederivate | |
DE3774273D1 (de) | Chinazolin-derivat, verfahren zu dessen herstellung und mittel zur behandlung von cerebraler disfunktion als aktiver inhaltsstoff. | |
ATE270287T1 (de) | 2,3-dihydro-1h-isoindolderivate, verfahren zu ihrer herstellung und ihre verwendung als hemmer der serotoninwiederaufnahme | |
NO20016029L (no) | N-Alkoksyalkyl-N,N-dialkylamin-derivater eller salter derav, og remedier for nervedegereringssykdommer inneholdende disse | |
NO842345L (no) | Heksahydropyrrolo(2,1-a)isoquinolin-derivater. | |
ITMI920082A1 (it) | Derivati solforati di acidi biliari | |
ATE180251T1 (de) | Indan derivate und verfahren zu deren herstellung | |
DE69401521D1 (de) | Piperidin-Derivate mit antihistaminischer und antileukomenischer Wirkung | |
ATE235488T1 (de) | Verfahren zu trennung von ftc isomere und deren derivate | |
RU94033470A (ru) | Циклогексановые производные, фармкомпозиция на их основе и способ лечения | |
ES2149180T3 (es) | Derivado de pirazolotiazolopirimidina. | |
DE69819315D1 (de) | Verfahren zur herstellung von piperidincarbonsäureamiden | |
TH6248EX (th) | กรรมวิธีการเตรียมอนุพันธ์ 2,4-ไดไฮโดร-3h-1,2,4-ไทรอะโซล-3-โอน | |
TH10820EX (th) | อนุพันธุ์ของกรดอมิโน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |